Inventor
Daniel V. Santi
Inventor
San Francisco, CA, US
Overview
Patents· 56 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
A61KPreparations for medical, dental or toiletry purposes10%
C07DHeterocyclic compounds10%
C12NMicroorganisms or enzymes9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture9%
C07HSugars6%
C40BCombinatorial chemistry6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
PatentTitleYear
10,413,594Conjugates of somatostatin analogues201910,398,779Hydrogels with biodegradable crosslinking201910,086,049Conjugates of somatostatin analogues20189,649,385'Hydrogels with biodegradable crosslinking'20179,387,254'Prodrugs and drug-macromolecule conjugates having controlled drug release rates'20168,946,405'Controlled release from solid supports'20158,754,190'Controlled release from macromolecular conjugates'20148,703,907'Controlled drug release from dendrimers'20148,680,315'Prodrugs and drug-macromolecule conjugates having controlled drug release rates'20148,003,687'Esters of compounds in the leptomycin family'20117,680,601'Design of polyketide synthase genes'20107,655,808'Leptomycin compounds'20107,601,852'Macrocyclic kinase inhibitors'20097,541,330'Conjugates with reduced adverse systemic effects'20097,446,196'Leptomycin compounds'20087,413,878'Recombinant host cells expressing atoAD and capable of making a polyketide using a starter unit'20087,405,208'Benzoquinone ansamycins'20087,378,407'Geldanamycin compounds and method of use'20087,291,486'Genetically modified cells and methods for converting (R)-methylmalonyl CoA to (S)-methylmalonyl CoA'20077,259,156'Geldanamycin compounds and method of use'2007RE039762'Polyketide synthase enzymes and recombinant DNA constructs therefor'20077,214,708'Synthetic discodermolide analogs'20077,078,233'Production of polyketides in bacteria and yeast'20067,049,100'Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides'20067,033,818'Recombinant polyketide synthase genes'20067,011,959'Heterologous production of polyketides'20066,946,482'Motilide compounds'20056,872,715'Benzoquinone ansamycins'20056,838,265'Overproduction hosts for biosynthesis of polyketides'20056,759,536'Polynucleotides encoding the fkbA gene of the FK-520 polyketide synthase gene cluster'20046,750,205'Motilide compounds'20046,660,862'Polyketide synthase enzymes and recombinant DNA constructs therefor'20036,624,302'Polyketide derivatives'20036,569,867'Polyketide derivatives'20036,562,795'Motilide compounds'20036,503,737'Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster'20036,399,789'Multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides'20026,258,566'Production of polyketides in bacteria and yeast'20016,075,121'Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such'20006,033,883'Production of polyketides in bacteria and yeast'20005,965,695'Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such'19995,840,841'Method and apparatus for biopolymer synthesis'19985,811,387'Peptoid mixtures'19985,734,018'Peptide mixtures'19985,705,610'Method and apparatus for biopolymer synthesis'19985,670,312'Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease'19975,641,862'General method for producing and selecting peptides with specific properties'19975,492,807'Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease'19965,438,119'Method of obtaining a peptide with desired target property'19955,420,246'Peptide mixtures'19955,266,684'Peptide mixtures'19935,252,296'Method and apparatus for biopolymer synthesis'19935,225,533'General method for producing and selecting peptides with specific properties'19935,182,366'Controlled synthesis of peptide mixtures using mixed resins'19935,164,490'Pneumocystis carinii dihydrofolate reductase gene and methods for its use'19925,010,175'General method for producing and selecting peptides with specific properties'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1998Patents assigned to UNIV CALIFORNIA (8)· patent assignee history
1991–2019Based in San Francisco, CA, US· patent location history
1993–2000Patents assigned to CHIRON CORP (6)· patent assignee history
1993–2017Patents assigned to SANTI DANIEL V (6)· patent assignee history
2000–2011Patents assigned to KOSAN BIOSCIENCES INC (29)· patent assignee history
2014–2019Patents assigned to PROLYNX LLC (9)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KOSAN BIOSCIENCES INC | 29 | 2000–2011 |
| PROLYNX LLC | 9 | 2014–2019 |
| UNIV CALIFORNIA | 8 | 1991–1998 |
| CHIRON CORP | 6 | 1993–2000 |
| SANTI DANIEL Vself | 6 | 1993–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 56 | 1991–2019 |